Drug class
Second-generation sulfonylurea antidiabetic
Mechanism of action
Binds the SUR1 regulatory subunit of ATP-sensitive potassium channels on pancreatic beta cells, promoting membrane depolarisation, calcium influx and glucose-dependent insulin secretion.
General use cases
- Treatment of type 2 diabetes mellitus when diet and exercise alone are insufficient.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
